Biopharma | June 29, 2025
Sartorius expands manufacturing and R&D capacities for bioprocess solutions in France
Extended lab space for product development, customer demos, and training
Extended lab space for product development, customer demos, and training
The 16,000-square-foot expansion enhances DuPont’s global sterile operations
The company recorded its quarterly consolidated revenue from operations at Rs. 61.22 crore in Q4 FY25
The CDMO upgrade represents a transformational step for Remedium Lifecare
The portfolio consists of liquids and immediate release solid orals which are in the therapeutic segment to treat infections associated with UTIs
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
A new weapon in the global fight against malaria
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
This collaboration positions WACKER and RNAV8 as premium mRNA service providers
Dupixent (dupilumab) approved as the first-ever biologic medicine in Japan for patients with Chronic Obstructive Pulmonary Disease (COPD)
Subscribe To Our Newsletter & Stay Updated
